205 related articles for article (PubMed ID: 22528947)
1. Expression of ezrin correlates with malignant phenotype of lung cancer, and in vitro knockdown of ezrin reverses the aggressive biological behavior of lung cancer cells.
Li Q; Gao H; Xu H; Wang X; Pan Y; Hao F; Qiu X; Stoecker M; Wang E; Wang E
Tumour Biol; 2012 Oct; 33(5):1493-504. PubMed ID: 22528947
[TBL] [Abstract][Full Text] [Related]
2. Ezrin silencing by small hairpin RNA reverses metastatic behaviors of human breast cancer cells.
Li Q; Wu M; Wang H; Xu G; Zhu T; Zhang Y; Liu P; Song A; Gang C; Han Z; Zhou J; Meng L; Lu Y; Wang S; Ma D
Cancer Lett; 2008 Mar; 261(1):55-63. PubMed ID: 18155831
[TBL] [Abstract][Full Text] [Related]
3. Aberrant hypermethylation and reduced expression of disabled-2 promote the development of lung cancers.
Xie XM; Zhang ZY; Yang LH; Yang DL; Tang N; Zhao HY; Xu HT; Li QC; Wang EH
Int J Oncol; 2013 Nov; 43(5):1636-42. PubMed ID: 24002585
[TBL] [Abstract][Full Text] [Related]
4. [Silencing of ezrin gene inhibits proliferation and invasion of human prostate cancer PC-3 cells].
Yang N; Wang L; Chen X; Liu J; Luo Z
Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2016 Jun; 32(6):821-4. PubMed ID: 27371852
[TBL] [Abstract][Full Text] [Related]
5. Knockdown of Ezrin by RNA interference reverses malignant behavior of human pancreatic cancer cells in vitro.
Zhong ZQ; Song MM; He Y; Cheng S; Yuan HS
Asian Pac J Cancer Prev; 2012; 13(8):3781-9. PubMed ID: 23098471
[TBL] [Abstract][Full Text] [Related]
6. Mechanisms underlying cancer progression caused by ezrin overexpression in tongue squamous cell carcinoma.
Saito S; Yamamoto H; Mukaisho K; Sato S; Higo T; Hattori T; Yamamoto G; Sugihara H
PLoS One; 2013; 8(1):e54881. PubMed ID: 23357878
[TBL] [Abstract][Full Text] [Related]
7. Silence of ezrin modifies migration and actin cytoskeleton rearrangements and enhances chemosensitivity of lung cancer cells in vitro.
Chen QY; Xu W; Jiao DM; Wu LJ; Song J; Yan J; Shi JG
Mol Cell Biochem; 2013 May; 377(1-2):207-18. PubMed ID: 23435957
[TBL] [Abstract][Full Text] [Related]
8. Silencing MTA1 by RNAi reverses adhesion, migration and invasiveness of cervical cancer cells (SiHa) via altered expression of p53, and E-cadherin/β-catenin complex.
Rao Y; Wang H; Fan L; Chen G
J Huazhong Univ Sci Technolog Med Sci; 2011 Feb; 31(1):1-9. PubMed ID: 21336715
[TBL] [Abstract][Full Text] [Related]
9. Altered expression of the ERM proteins in lung adenocarcinoma.
Tokunou M; Niki T; Saitoh Y; Imamura H; Sakamoto M; Hirohashi S
Lab Invest; 2000 Nov; 80(11):1643-50. PubMed ID: 11092524
[TBL] [Abstract][Full Text] [Related]
10. [Expression of ezrin in human non-small cell lung cancer and its relationship with metastasis and prognosis].
Chen QY; Yan J; Hu HZ; Chen FY; Song J; Jiang ZY; Jiao DM; Wu YQ
Zhonghua Zhong Liu Za Zhi; 2012 Jun; 34(6):436-40. PubMed ID: 22967445
[TBL] [Abstract][Full Text] [Related]
11. MiRNA-199 inhibits malignant progression of lung cancer through mediating RGS17.
Su WZ; Ren LF
Eur Rev Med Pharmacol Sci; 2019 Apr; 23(8):3390-3400. PubMed ID: 31081094
[TBL] [Abstract][Full Text] [Related]
12. Expression and clinical significance of ezrin in non--small-cell lung cancer.
Zhang XQ; Chen GP; Wu T; Yan JP; Zhou JY
Clin Lung Cancer; 2012 May; 13(3):196-204. PubMed ID: 22137559
[TBL] [Abstract][Full Text] [Related]
13. MicroRNA-144 inhibits the proliferation, apoptosis, invasion, and migration of osteosarcoma cell line F5M2.
Cui SQ; Wang H
Tumour Biol; 2015 Sep; 36(9):6949-58. PubMed ID: 25854173
[TBL] [Abstract][Full Text] [Related]
14. The role of the membrane cytoskeleton cross-linker ezrin in medulloblastoma cells.
Osawa H; Smith CA; Ra YS; Kongkham P; Rutka JT
Neuro Oncol; 2009 Aug; 11(4):381-93. PubMed ID: 19088174
[TBL] [Abstract][Full Text] [Related]
15. [Potential role of ezrin and its related microRNA in ovarian cancer invasion and metastasis].
Li J; Liang SH; Lu X
Zhonghua Fu Chan Ke Za Zhi; 2010 Oct; 45(10):787-92. PubMed ID: 21176563
[TBL] [Abstract][Full Text] [Related]
16. Ezrin promotes ovarian carcinoma cell invasion and its retained expression predicts poor prognosis in ovarian carcinoma.
Köbel M; Gradhand E; Zeng K; Schmitt WD; Kriese K; Lantzsch T; Wolters M; Dittmer J; Strauss HG; Thomssen C; Hauptmann S
Int J Gynecol Pathol; 2006 Apr; 25(2):121-30. PubMed ID: 16633060
[TBL] [Abstract][Full Text] [Related]
17. TC-1 (c8orf4) enhances aggressive biologic behavior in lung cancer through the Wnt/β-catenin pathway.
Su K; Huang L; Li W; Yan X; Li X; Zhang Z; Jin F; Lei J; Ba G; Liu B; Wang X; Wang Y
J Surg Res; 2013 Nov; 185(1):255-63. PubMed ID: 23880650
[TBL] [Abstract][Full Text] [Related]
18. Abnormal ezrin localization is associated with clinicopathological features in invasive breast carcinomas.
Sarrió D; Rodríguez-Pinilla SM; Dotor A; Calero F; Hardisson D; Palacios J
Breast Cancer Res Treat; 2006 Jul; 98(1):71-9. PubMed ID: 16538541
[TBL] [Abstract][Full Text] [Related]
19. Knockdown of ezrin via RNA interference suppresses Helicobacter pylori-enhanced invasion of gastric cancer cells.
Fan LL; Chen DF; Lan CH; Liu KY; Fang DC
Cancer Biol Ther; 2011 Apr; 11(8):746-52. PubMed ID: 21282970
[TBL] [Abstract][Full Text] [Related]
20. ERM stable knockdown by siRNA reduced in vitro migration and invasion of human SGC-7901 cells.
Ou-Yang M; Liu HR; Zhang Y; Zhu X; Yang Q
Biochimie; 2011 May; 93(5):954-61. PubMed ID: 21352885
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
